Cinda International Holdings Limited - 0111.HK

0111.HK Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
0111.HK	2	3.7	0	-20.3	10.9	-1.9	-41.4	-23.9	-83	-72.7
S&P 500	0.3	1.8	2.1	5.3	9.8	25.4	38.4	83.5	197.4	34452.8

Compare 0111.HK with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	0111.HK
name	Cinda International Holdings Limited
price	0.255
changes percentage	2
change	0.005
day low	0.255
day high	0.255
year high	0.67
year low	0.205
market cap	163507530
price avg 50	0.25868
price avg 200	0.25778
exchange	HKSE
volume	8000
avg volume	318580
open	0.255
previous close	0.25
eps	-0.02
pe	-12.75
earnings announcement	2024-08-27T10:58:01.000+0000
shares outstanding	641206000
timestamp	2025-01-23 07:55:46

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 39.7%

Overall Quarterly Financial Health: 58.3%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
revenue	145640000	127208000	14.49
gross profit	81406000	87909000	-7.40
gross profit ratio	0.56	0.69	-19.12
research and development expenses	0	-0.14	100.00
operating expenses	81406000	88710000	-8.23
interest income	-268000	0	NaN
interest expense	26325000	20634000	27.58
ebitda	28047000	26603000	5.43
ebitdaratio	0.19	0.21	-7.91
operating income	11442000	-801000	1528.46
operating income ratio	0.08	-0.01	1347.68
net income	-12849000	-22408000	42.66
net income ratio	-0.09	-0.18	49.92
eps	-0.02	-0.03	42.69

Overall Score of Annual Income Statement

None

Detailed Analysis

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2023Q4	Q/Q change %
0000000000
revenue	86649000	78144000	10.88
gross profit	73755000	66272000	11.29
gross profit ratio	0.85	0.85	0.37
research and development expenses	0	0	NaN
operating expenses	-58950000	58374000	-200.99
interest income	0	0	NaN
interest expense	0	14364000	-100.00
ebitda	24615000	13642000	80.44
ebitdaratio	0.28	0.17	62.72
operating income	14805000	3473000	326.29
operating income ratio	0.17	0.04	284.45
net income	13132000	-13125000	200.05
net income ratio	0.15	-0.17	190.23
eps	0.02	-0.02	200.00

Overall Score of Quarterly Income Statement

0.86 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 87 million in 2024Q2 from 78 million in 2023Q4 representing a change of 10.88%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 74 million in 2024Q2 from 66 million in 2023Q4 representing a change of 11.29%. This indicates a sales profitability growth, which is a positive sign for the company.

  Operating Expenses: Operating Expenses decreased to -59 million in 2024Q2 from 58 million in 2023Q4 representing a change of -200.99%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 25 million in 2024Q2 from 14 million in 2023Q4 representing a change of 80.44%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Net Income: Net income increased to 13 million in 2024Q2 from -13 million in 2023Q4 representing a change of 200.05%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 0.02 in 2024Q2 from 0.02 in 2023Q4 representing a change of 200.0%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Operating Income: Operating income decreased to 15 million in 2024Q2 from 3 million in 2023Q4 representing a change of 326.29%. The decrease in operating income indicates worse operational performance and decreased profitability.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
total assets	1646468000	1665710000	-1.16
total liabilities	706335000	717597000	-1.57
total equity	940133000	948113000	-0.84
cash and cash equivalents	519331000	599209000	-13.33
short term investments	266352000	144180000	84.74
long term investments	480336000	474694000	1.19
total current assets	1118777000	587044000	90.58
total non current assets	527691000	58149000	807.48
total current liabilities	696054000	35630000	1853.56
total non current liabilities	10281000	28645000	-64.11
common stock	64120999	64120999	0.00
retained earnings	433269000	446118000	-2.88
total debt	513453000	507524000	1.17

Overall Score of Annual Balance Sheet

0.33 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Assets: Total Assets decreased to 1,646 million in 2023 from 1,666 million in 2022 representing a change of -1.16%. Suggesting a decrease in asset holdings.

  Total Equity: Total Equity decreased to 940 million in 2023 from 948 million in 2022 representing a change of -0.84%. This indicates a decrease in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 519 million in 2023 from 599 million in 2022 representing a change of -13.33%. This indicates a decrease in available liquid assets.

  Total Current Liabilities: Total Current Liabilities increased to 696 million in 2023 from 36 million in 2022 representing a change of 1853.56%. This indicates a higher short-term debt burden.

  Retained Earnings: Retained Earnings decreased to 433 million in 2023 from 446 million in 2022 representing a change of -2.88%. This indicates an accumulated losses.

  Total Debt: Total Debt increased to 513 million in 2023 from 508 million in 2022 representing a change of 1.17%. This indicates an increase in overall debt burden.

• 📈 Positive Indicators

  Total Liabilities: Total Liabilities decreased to 706 million in 2023 from 718 million in 2022 representing a change of -1.57%. This indicates a decrease in overall liabilities.

  Short Term Investments: Short Term Investments increased to 266 million in 2023 from 144 million in 2022 representing a change of 84.74%. This indicates an increase in short-term investment holdings.

  Total Current Assets: Total Current Assets increased to 1,119 million in 2023 from 587 million in 2022 representing a change of 90.58%. This indicates a better liquidity position.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q2	2023Q4	Q/Q change %
0000000000
total assets	1769687000	1646468000	7.48
total liabilities	830375000	706335000	17.56
total equity	939312000	940133000	-0.09
cash and cash equivalents	532019000	531778000	0.05
short term investments	455294000	266351999	70.94
long term investments	0	480336000	-100.00
total current assets	0	1118777000	-100.00
total non current assets	0	527691000	-100.00
total current liabilities	674252000	696054000	-3.13
total non current liabilities	153881000	10281000	1396.75
common stock	64120999	64120999	0.00
retained earnings	446401000	433269000	3.03
total debt	676494000	513453000	31.75

Overall Score of Quarterly Balance Sheet

0.56 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 1,770 million in 2024Q2 from 1,646 million in 2023Q4 representing a change of 7.48%. Suggesting a growth in asset holdings.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 532 million in 2024Q2 from 532 million in 2023Q4 representing a change of 0.05%. This indicates an increase in available liquid assets.

  Short Term Investments: Short Term Investments increased to 455 million in 2024Q2 from 266 million in 2023Q4 representing a change of 70.94%. This indicates an increase in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities decreased to 674 million in 2024Q2 from 696 million in 2023Q4 representing a change of -3.13%. This indicates a lower short-term debt burden.

  Retained Earnings: Retained Earnings increased to 446 million in 2024Q2 from 433 million in 2023Q4 representing a change of 3.03%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 830 million in 2024Q2 from 706 million in 2023Q4 representing a change of 17.56%. This indicates an increase in overall liabilities.

  Total Equity: Total Equity decreased to 939 million in 2024Q2 from 940 million in 2023Q4 representing a change of -0.09%. This indicates a decrease in shareholders' equity.

  Total Current Assets: Total Current Assets decreased to 0 million in 2024Q2 from 1,119 million in 2023Q4 representing a change of -100.0%. This indicates a worsen liquidity position.

  Total Debt: Total Debt increased to 676 million in 2024Q2 from 513 million in 2023Q4 representing a change of 31.75%. This indicates an increase in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
net change in cash	-67713000	-194072000	65.11
operating cash flow	55057000	8883000	519.80
free cash flow	53687000	5117000	949.19
capital expenditure	-1370000	-3766000	63.62
depreciation and amortization	23586000	27404000	-13.93
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts payables	-21942000	-72289000	69.65
inventory	0	0	NaN
acquisitions net	13000	92000	-85.87
investments in property plant and equipment	-1370000	-3766000	63.62
net cash used for investing activites	-99756000	166324000	-159.98
debt repayment	27420000	-315581000	108.69
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	0	-12824000	100.00
net cash used provided by financing activities	-19038000	-351330000	94.58
cash at end of period	519331000	599209000	-13.33
accounts receivables	46200000	66429000	-30.45
cash at beginning of period	587044000	793281000	-26.00

Overall Score of Annual Cashflow Statement

0.86 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to -68 million in 2023 from -194 million in 2022 representing a change of 65.11%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 55 million in 2023 from 9 million in 2022 representing a change of 519.8%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 54 million in 2023 from 5 million in 2022 representing a change of 949.19%. This indicates an increase in cash generated after accounting for capital expenditures.

  Accounts Payables: The absolute value of Accounts Payables decreased to 22 million in 2023 from 72 million in 2022 representing a change of 69.65%. This indicates that the company has reduced its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables decreased to 46 million in 2023 from 66 million in 2022 representing a change of -30.45%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

  Dividends Paid: Dividends Paid increased to 0 million in 2023 from -13 million in 2022 representing a change of 100.0%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

• 📉 Negative Indicators

  Capital Expenditure: Capital Expenditure increased to -1 million in 2023 from -4 million in 2022 representing a change of 63.62%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2023Q4	Q/Q change %
0000000000
operating cash flow	31391000	14866000	111.16
free cash flow	30888000	13840000	123.18
capital expenditure	-503000	-1026000	50.97
depreciation and amortization	9810000	10169000	-3.53
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts receivables	53853000	11119000	384.33
accounts payables	-37499000	-13555000	-176.64
inventory	0	0	NaN
acquisitions net	0	4000	-100.00
investments in property plant and equipment	-503000	-1026000	50.97
net cash used for investing activites	-192943000	-8518000	-2165.12
debt repayment	0	0	NaN
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	0	0	NaN
net cash used provided by financing activities	163041000	25879000	530.01
net change in cash	241000	44517000	-99.46
cash at end of period	532019000	531778000	0.05
cash at beginning of period	531778000	487261000	9.14

Overall Score of Quarterly Cashflow Statement

0.33 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to 0 million in 2024Q2 from 45 million in 2023Q4 representing a change of -99.46%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Capital Expenditure: Capital Expenditure increased to -1 million in 2024Q2 from -1 million in 2023Q4 representing a change of 50.97%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Accounts Payables: The absolute value of Accounts Payables increased to 37 million in 2024Q2 from 14 million in 2023Q4 representing a change of -176.64%. This indicates that the company has increased its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables increased to 54 in 2024Q2 from 11 million in 2023Q4 representing a change of 384.33%. This suggests that the company is less capable of collecting payments from its customers.

• 📈 Positive Indicators

  Operating Cash Flow: Operating Cash Flow increased to 31 million in 2024Q2 from 15 million in 2023Q4 representing a change of 111.16%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 31 million in 2024Q2 from 14 million in 2023Q4 representing a change of 123.18%. This indicates an increase in cash generated after accounting for capital expenditures.

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	0.23	0.2	14.49
net income per share	-0.02	-0.03	42.66
operating cash flow per share	0.09	0.01	519.80
free cash flow per share	0.08	0.01	949.19
cash per share	1.23	1.16	5.69
book value per share	1.47	1.48	-0.84
tangible book value per share	1.46	1.48	-0.84
shareholders equity per share	1.47	1.48	-0.84
interest debt per share	0.84	0.82	2.20
market cap	169919484	230834016	-26.39
enterprise value	164041484	139149016	17.89
pe ratio	-13.22	-10.3	-28.37
price to sales ratio	1.17	1.81	-35.71
pocfratio	3.09	25.99	-88.12
pfcf ratio	3.17	45.11	-92.98
pb ratio	0.18	0.24	-25.76
ptb ratio	0.18	0.24	-25.76
ev to sales	1.13	1.09	2.97
enterprise value over ebitda	5.85	5.23	11.82
ev to operating cash flow	2.98	15.66	-80.98
ev to free cash flow	3.06	27.19	-88.76
earnings yield	-0.08	-0.1	22.10
free cash flow yield	0.32	0.02	1325.31
debt to equity	0.55	0.54	2.03
debt to assets	0.31	0.3	2.35
net debt to ebitda	-0.21	-3.45	93.92
current ratio	1.61	16.48	-90.24
interest coverage	0.43	-0.04	1219.66
income quality	-327.72	-0.4	-82569.76
dividend yield	0	0.06	-100.00
payout ratio	0	-0.57	100.00
sales general and administrative to revenue	0.05	0.08	-33.25
research and ddevelopement to revenue	0	-0.0	100.00
intangibles to total assets	0.0	0.0	1.17
capex to operating cash flow	0.02	0.42	-94.13
capex to revenue	0.01	0.03	-68.23
capex to depreciation	0.06	0.14	-57.73
stock based compensation to revenue	0	0	NaN
graham number	0.81	1.08	-24.60
roic	0.01	-0.0	1102.77
return on tangible assets	-0.01	-0.01	41.99
graham net net	0.12	0.48	-74.16
working capital	422723000	551414000	-23.34
tangible asset value	938694000	946674000	-0.84
net current asset value	412442000	-130553000	415.92
invested capital	458637000	609563000	-24.76
average receivables	187501000	408654500	-54.12
average payables	158520500	188229500	-15.78
average inventory	0	0	NaN
days sales outstanding	0	1076.0	-100.00
days payables outstanding	839.08	1573.13	-46.66
days of inventory on hand	0	0	NaN
receivables turnover	0	0.34	-100.00
payables turnover	0.43	0.23	87.48
inventory turnover	0	0	NaN
roe	-0.01	-0.02	42.17
capex per share	0.0	0.01	-63.62

• Negative

  ROE: Return on Equity (ROE) increased to -0.01 on 2023-12-31 from -0.02 on 2022-12-31, representing a change of 42.17%. However, ROE is <= 5%, suggesting that the company has not been generating high returns for its shareholders.

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to -13.22 on 2023-12-31 from -10.30 on 2022-12-31, representing a change of -28.37%. Indicating a decrease in the relative valuation of the company's stock.

• Neutral

  Current Ratio: Current Ratio decreased to 1.61 on 2023-12-31 from 16.48 on 2022-12-31, representing a change of -90.24%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.55 on 2023-12-31 from 0.54 on 2022-12-31, representing a change of 2.03%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Quarterly Financial Ratios

	2024-06-30 Q2	2023-12-31 Q4	Q/Q change %
0111.HK
calendar year	2024	2023	NaN
revenue per share	0.14	0.12	10.88
net income per share	0.02	-0.02	200.05
operating cash flow per share	0.05	0.02	111.16
free cash flow per share	0.05	0.02	123.18
cash per share	1.54	1.24	23.70
book value per share	1.46	1.47	-0.09
tangible book value per share	1.46	1.46	-0.09
shareholders equity per share	1.46	1.47	-0.09
interest debt per share	1.06	0.82	28.17
market cap	151324521.6	169919484	-10.94
enterprise value	295799521.6	151594484	95.13
pe ratio	2.88	-3.24	189.01
price to sales ratio	1.75	2.17	-19.68
pocfratio	4.82	11.43	-57.82
pfcf ratio	4.9	12.28	-60.10
pb ratio	0.16	0.18	-10.87
ptb ratio	0.16	0.18	-10.87
ev to sales	3.41	1.94	75.97
enterprise value over ebitda	12.02	11.11	8.14
ev to operating cash flow	9.42	10.2	-7.59
ev to free cash flow	9.58	10.95	-12.57
earnings yield	0.09	-0.08	212.35
free cash flow yield	0.2	0.08	150.60
debt to equity	0.72	0.55	31.87
debt to assets	0.38	0.31	22.58
net debt to ebitda	5.87	-1.34	536.95
current ratio	0	1.61	-100.00
interest coverage	0	0.24	-100.00
income quality	2.39	-1.13	311.05
dividend yield	0	0	NaN
payout ratio	0	0	NaN
sales general and administrative to revenue	0	0.45	-100.00
research and ddevelopement to revenue	0	0	NaN
intangibles to total assets	0.0	0.0	-6.96
capex to operating cash flow	0.02	0.07	-76.78
capex to revenue	0.01	0.01	-55.79
capex to depreciation	0.05	0.1	-49.18
stock based compensation to revenue	0	0	NaN
graham number	0.82	0.82	-0.02
roic	0	0.0	-100.00
return on tangible assets	0.01	-0.01	193.08
graham net net	0.54	0.52	3.99
working capital	-674252000	422723000	-259.50
tangible asset value	937873000	938694000	-0.09
net current asset value	-830375000	412442000	-301.33
invested capital	-647622000	458637000	-241.21
average receivables	286054500	331295000	-13.66
average payables	73832500	152359000	-51.54
average inventory	0	0	NaN
days sales outstanding	261.19	369.3	-29.27
days payables outstanding	0	1119.43	-100.00
days of inventory on hand	0	0	NaN
receivables turnover	0.34	0.24	41.39
payables turnover	0	0.08	-100.00
inventory turnover	0	0	NaN
roe	0.01	-0.01	200.14
capex per share	0.0	0.0	-50.97

• Negative

  ROE: Return on Equity (ROE) increased to 0.01 on 2024-06-30 Q2 from -0.01 on 2023-12-31 Q4, representing a change of 200.14%. However, ROE is <= 5%, suggesting that the company has not been generating high returns for its shareholders.

  Current Ratio: Current Ratio decreased to 0.00 on 2024-06-30 Q2 from 1.61 on 2023-12-31 Q4, representing a change of -100.00%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. Also, it's below 1, indicating potential liquidity issues.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 2.88 on 2024-06-30 Q2 from -3.24 on 2023-12-31 Q4, representing a change of 189.01%. Indicating an increase in the relative valuation of the company's stock.

• Neutral

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.72 on 2024-06-30 Q2 from 0.55 on 2023-12-31 Q4, representing a change of 31.87%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

None